-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $308

Benzinga·07/27/2026 18:20:46
Listen to the news
UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $288 to $308.